WSJ Says FTC Increasingly Unlikely to Block Deal Between Medco (MHS), Express Scripts (ESRX)
Tweet
Share
E-mailGet Alerts MHS Hot Sheet
Join SI Premium – FREE
Medco (NYSE: MHS) shares are ticking higher over just the last few minutes of trade as WSJ is reporting the FTC is becoming increasingly unlikely to block the deal between the company and Express Scripts (Nasdaq: ESRX).
Shares of Medco last traded at $68.30, up about 1 percent from Thursday's close.
Shares of Medco last traded at $68.30, up about 1 percent from Thursday's close.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- CoStar Group acquires Zonda for $800M, adding new home data
- Holcim to acquire Fermacell from James Hardie for EUR 840M
Create E-mail Alert Related Categories
Mergers and Acquisitions, Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
